Back
BILL Holdings Vs. Blueprint Medicines Industry Stock Comparison
Buy
63
BILL
BILL Holdings
Last Price:
$46.55
Seasonality Move:
19.13%
Buy
53
BPMC
Blueprint Medicines
Last Price:
$129.46
Seasonality Move:
1.87%
Buy
63
BILL Holdings (BILL)
is a Buy
Is BILL Holdings a Buy, Sell or Hold?
-
The current BILL Holdings [BILL] share price is $46.07. The Score for BILL is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
BILL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
53
Blueprint Medicines (BPMC)
is a Buy
Is Blueprint Medicines a Buy, Sell or Hold?
-
The current Blueprint Medicines [BPMC] share price is $129.46. The Score for BPMC is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
BPMC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BILL Stock Price Chart
What is BILL Holdings's stock price today?
-
The BILL Holdings share price today is $46.07Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BILL is experiencing buying pressure, which is a positive indicator for future bullish movement.
BPMC Stock Price Chart
What is Blueprint Medicines's stock price today?
-
The Blueprint Medicines share price today is $129.46Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing slight buying pressure.
BILL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.27 | Buy |
Relative Strength Index (14 RSI): | 51.16 | Buy |
Chaikin Money Flow: | 927291 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.89 - 47.27) | Buy |
Bollinger Bands (100): | (42.62 - 48.52) | Buy |
BPMC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.34 | Buy |
Relative Strength Index (14 RSI): | 76.66 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (128.13 - 129.21) | Buy |
Bollinger Bands (100): | (86.05 - 122.97) | Buy |
BILL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 45.88 | Buy |
20-day SMA: | 46.25 | Sell |
50-day SMA: | 45.37 | Buy |
200-day SMA: | 60.99 | Sell |
8-day EMA: | 46.07 | Buy |
20-day EMA: | 45.93 | Buy |
50-day EMA: | 46.08 | Sell |
200-day EMA: | 55.25 | Sell |
BPMC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 129.39 | Buy |
20-day SMA: | 128.78 | Buy |
50-day SMA: | 119.98 | Buy |
200-day SMA: | 100.05 | Buy |
8-day EMA: | 129.3 | Buy |
20-day EMA: | 128.05 | Buy |
50-day EMA: | 120.46 | Buy |
200-day EMA: | 103.98 | Buy |
BILL Holdings Earnings Growth & BILL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.03 per share, and an increase next year of $0.10 per share.
Blueprint Medicines Earnings Growth & BPMC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.52 per share, an increase next quarter of $0.48 per share, an increase this year of $0.60 per share, and an increase next year of $1.59 per share.
BILL Holdings Technical Analysis
Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Blueprint Medicines Technical Analysis
Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |